Cystatin C in diabetics as a marker of mild renal insufficiency after CABG

Annals of Thoracic and Cardiovascular Surgery

Volumn 17, Issue 3, 2011, Pages 277-282

  Jarvela, Kati ^a   Maaranen, Pasi ^a   Harmoinen, Aimo ^b   Huhtala, Heini ^c   Sisto, Tero ^a  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b ISLAB   (Finland)

^c TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

Acute renal failure; Cardiac surgery; Cystatin C; Diabetes mellitus; Renal function markers

Indexed keywords

BIOLOGICAL MARKER; CREATININE; CST3 PROTEIN, HUMAN; CYSTATIN C; DIURETIC AGENT; FUROSEMIDE;

ACUTE KIDNEY FAILURE; AGED; ARTICLE; BLOOD; CHI SQUARE DISTRIBUTION; COMPARATIVE STUDY; CORONARY ARTERY BYPASS GRAFT; DIABETES MELLITUS; ELECTIVE SURGERY; FINLAND; GLOMERULUS FILTRATION RATE; HOSPITALIZATION; HUMAN; MIDDLE AGED; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; TIME; TREATMENT OUTCOME;

ACUTE KIDNEY INJURY; AGED; BIOLOGICAL MARKERS; CHI-SQUARE DISTRIBUTION; CORONARY ARTERY BYPASS; CREATININE; CYSTATIN C; DIABETES MELLITUS; DIURETICS; FINLAND; FUROSEMIDE; GLOMERULAR FILTRATION RATE; HUMANS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SURGICAL PROCEDURES, ELECTIVE; TIME FACTORS; TREATMENT OUTCOME;

EID: 79959697548     PISSN: 13411098     EISSN: None     Source Type: Journal    
DOI: 10.5761/atcs.oa.10.01577     Document Type: Article

References (23)

1. Mangano CM, Diamondstone LS, Ramsay JG, Aggarwal A, Herskowitz A, et al. Renal dysfunction after myocardial revascularisation: Risk factors, adverse outcomes, and hospital resource utilization. The multicenter study of perioperative ischemia researchgroup. Ann Intern Med 1998; 128: 194-203.
2. Chertow GM, Levy EM, Hammermeister KE, Grover F, Daley J. Independent association between acute renal failure and mortality following cardiac surgery. Am J Med 1998; 104: 343-8.
3. Bahar I, Akgul A, Ozatik M, Vural KM, Demirbag AE, et al. Acute renal failure following open heart surgery: risk factors and prognosis. Perfusion 2005; 20: 317-22.
4. Hitoshi H, Amano A, Takahashi A, Nagano N. Coronary artery bypass grafting for patients with non-dialysis-dependent renal dysfunction (serum creatinine ≥ 2.0 mg/dl). Eur J Cardiothorac Surg 2001; 20: 565-72.
5. Newman DJ, Price CP. Renal function and nitrogen metabolites. In: Burtis CA, Ashwood ER, eds. Tietz textbook of clinical chemistry. Philadelphia: WB Saunders, 1999; pp 1204-70.
6. James GD, Sealey JE, Alderman M, Ljungman S, Mueller FB, et al. A longitudinal study of urinary creatinine and creatinine clearance in normal subjects. Race, sex and age differences. Am J Hypertens 1988; 1: 124-31.
7. Abrahamson M, Olafsson I, Palsdottir A, Ulvsback M, Lundwall A, et al. Structure and expression of the human cystatin C gene. Biochem J 1990; 268: 287-94.
8. Grubb A. Diagnostic value of analysis of cystatin C and protein HC in biological fluids. Clin Nephrol 1992; 38: S20-7.
9. Laterza OF, Price CP, Scott MG. Cystatin C: an improved estimation of glomerular filtration rate? Clin Chem 2002; 48: 699-707.
10. Harmoinen AP, Kouri TT, Wirta OR, Lehtimäki TJ, Rantalaiho V et al. Evaluation of plasma cystatin C as a marker for glomerular filtration rate in patients with type two diabetes. Clin Nephrol 1999; 52: 363-70.
11. Hannan EL, Racz MJ, Walford G, Jones RH, Ryan TJ, et al. Long-term outcomes of coronary-artery bypass grafting versus stent implantation. N Engl J Med 2005; 352: 2174-83.
12. Nashef SAM, Roques F, Hammil BG, Peterson ED, Michel P, et al. Validation of European system for cardiac operative risk evaluation (EuroSCORE) in North American cardiac surgery. Eur J Cardiothorac Surg 2002; 22: 101-5.
13. National Kidney Foundation (2002) K/DOQI clinical practice quidelines for chronic kidney disease: evaluation, classification and stratification. Kideney Disease Outcome Quality Initiative. Am J Kidney Dis 2002; 39: S76-S110.
14. Hoek FJ, Kemperman FAW, Krediet RT. A comparison between cystatin C, plasma creatinine and the Cockcroft and Gault formula for the estimation of glomerular filtration rate. Nephrol Dial Transplant 2003; 18: 2024-31.
15. Tidman M, Sjostrom P, Jones I. A Comparison of GFR estimating formulae based upon s-cystatin C and s-creatinine and a combination of the two. Nephrol Dial Transplant 28; 23: 154-60.
16. Yashiro M, Kamata T, Segawa H, Kadoya Y, Murakami T, et al. Comparisons of cystatin c with creatinine for evaluation of renal function in chronic kidney disease. Clin Exp Nephrol 2009; 13: 598-604.
17. Redfors B, Bragadottir G, Sellgren J, Sward K, Ricksten S. Dopamine increases renal oxygenation: a clinical study in post-cardiac surgery patients. Acta Anaesthesiol Scand 2010; 54: 183-90.
18. Lombardi R, Ferreiro A, Servetto C. Renal function after cardiac surgery: adverse effect of furosemide. Ren Fail 2003; 25: 775-86.
19. Shilliday IR, Quinn KJ, Allison MEM. Loop diuretics in the management of acute renal failure: a prospective, double-blind, placebo-controlled, randomized study. Nephrol Dial Transplant 1997; 12: 2592-6.
20. Herget-Rosenthal S, Marggraf G, Husing J, Göring F, Pietruck F, et al. Early detection of acute renal failure by serum cystatin C. Kidney Int 2004; 66: 1115-22.
21. Thervet E, Le Bricon T, Hugot V, Benlakehal M, Bedrossian J, et al. diagnosis of renal function recovery by cystatin C in renal allograft recipients. Transplant Proc 2000; 32: 2779.
22. Westhuyzen J, Endre ZH, Reece G, Reith DM, Saltissi D, et al. Measurement of tubular enzymuria facilitates early detection of acute renal impairment in the intensive care unit. Nephrol Dial Transplant 2003; 18: 543-1.
23. Paajanen H, Harmoinen A, Sisto T, Tarkka M, Nordback I. Postoperative hyperamylasaemia in cardiac surgery. Scand Cardiovasc J 1997; 31: 137-40.